
Join to view full profile
1100 9th AveSeattle, WA 98101
Phone+1 206-223-6600
Dr. Buckner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Rheumatology, 1995 - 1999
U Washington Affil Hosps1992 - 1996
U Washington Affil Hosps1992 - 1995
U Minnesota1991 - 1992
Minneapolis VA1990 - 1991
Certifications & Licensure
WA State Medical License 1992 - 2027
MN State Medical License 1989 - 1993
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the ra...Paul Emery, Michael E Weinblatt, Vivian P Bykerk, Andrew P Cope, Yoshiya Tanaka
Annals of the Rheumatic Diseases. 2026-07-09 - Association of Epigenetic Trajectory With Development of Clinical Rheumatoid Arthritis in Individuals With Anti-Citrullinated Protein Antibody Positivity: Targeting Im...E Barton Prideaux, David L Boyle, Eunice Choi, Jane H Buckner, William H Robinson
Arthritis & Rheumatology. 2026-04-22 - 5 citationsA coding single nucleotide polymorphism in the interleukin-6 receptor enhances IL-6 signalling in CD4 T cells and predicts treatment response to tocilizumab in giant c...Robert Zorc, Christopher Redmond, McKella Sylvester, Mary Maclean, Luciana Yamamoto de Almeida
Annals of the Rheumatic Diseases. 2025-08-01
Journal Articles
- Autoantibodies Against Neurologic Antigens in Nonneurologic AutoimmunityJane H Buckner, David A Hafler, Richard J Nowak, The Journal of Immunology
- Citrullinated Aggrecan Epitopes as Targets of Auto‐Reactive CD4+ T Cells in Patients with Rheumatoid ArthritisJeffrey Carlin, Jane H Buckner, Eddie A James, Mariana J Kaplan, Arthritis & Rheumatology
- Research Paper A Novel and Rapid Method to Quantify Treg Mediated Suppression of CD4 T CellsJane H. Buckner, Carmen Mikacenic, ScienceDirect
Books/Book Chapters
Abstracts/Posters
- Multiple alterations in IL-2R signaling contribute to decreased response to IL-2 in CD4+ T cells of T1D subjects as revealed by genotype/phenotype analysis.Long SA, Cerosaletti K, Shilling H, Zhang S, Zhang Z-Y, Pihoker C, Greenbaum C, Buckner J, Tolerance and Autoimmunity Keystone Symposium, Taos, NM
- Rapamycin Promotes Induction of CD4+FoxP3+ T cells that Proliferate in Response to Common Gamma Chain Cytokines.Long SA, Van Landeghen M., Buckner, JH, Oral presentation, Federation of Clinical Immunology Societies (FOCIS) conference, San Diego, CA
- Genetic Variation in PTPN22 Corresponds to Altered Signaling in B Lymphocytes.Arechiga AF, Buckner JH, American Association of Immunologists meeting, Miami, FL
Lectures
- Genotype-phenotype analysis reveals common disease mechanisms in autoimmunity.University of California, San Francisco, and Genentech, San Francisco, CA
- Update on Arthritis Research: Striving for a Cure Together.The Arthritis Foundation, Pacific Northwest Chapter, Shoreline, WA
- T Cell Immunoregulation.University of Oxford, 14th EASD Oxford Workshop, Oxford, United Kingdom
Other
- Polychondritis.Compton N, Buckner JH, Harp KI, Raugi GJ, eMedicine online book
http://emedicine.medscape.com/article/331475-overview
Press Mentions
Benaroya Research Institute — a Global Resource for Disease ResearchersNovember 20th, 2025
Age-Related T Cell Changes Weaken Vaccine Response in Older PeopleOctober 29th, 2025- New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the MicrobiomeMarch 10th, 2021
Grant Support
- Microbial Drivers and Pathogenic Mechanisms in Rheumatoid Arthritis Natural HistoryUNIVERSITY OF COLORADO DENVER2026–2031
- Regulatory T cells maintain immune homeostasis through translation controlBENAROYA RESEARCH INST AT VIRGINIA MASON2023–2028
- Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLEBENAROYA RESEARCH INST AT VIRGINIA MASON2023–2028
- Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLEBENAROYA RESEARCH INST AT VIRGINIA MASON2023–2028
- Immune Tolerance NetworkBENAROYA RESEARCH INST AT VIRGINIA MASON2014–2028
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









